These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 30049369)

  • 1. Erratum to: Derks JL, Leblay N, Lantuejoul S, Dingemans A-M, Speel, E-JM, Fernandez-Cuesta L. New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management. J Thorac Oncol. 2018;13(6):752-766.
    J Thorac Oncol; 2018 Aug; 13(8):1229. PubMed ID: 30049369
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum to: Kiesgen S, Chicaybam L, Chintala N.K, Adusumilli P.S. Chimeric antigen receptor (CAR) t-cell therapy for thoracic malignancies. J Thorac Oncol. 2018;13(1):16-26.
    J Thorac Oncol; 2018 Aug; 13(8):1229. PubMed ID: 30049370
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to: Pyo KH, Lim SM, Kim HR, Sung YH, Yun MR, Kim S-M, et al. Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Postive Human Non-Small Cell Lung Cancer. J Thorac Oncol. 2017;12(3):491-500.
    J Thorac Oncol; 2017 Dec; 12(12):1859. PubMed ID: 29169522
    [No Abstract]   [Full Text] [Related]  

  • 5. Erratum for the Report "A precise measurement of the magnetic field in the corona of the black hole binary V404 Cygni" by Y. Dallilar, S. S. Eikenberry, A. Garner, R. D. Stelter, A. Gottlieb, P. Gandhi, P. Casella, V. S. Dhillon, T. R. Marsh, S. P. Littlefair, L. Hardy, R. Fender, K. Mooley, D. J. Walton, F. Fuerst, M. Bachetti, A. J. Castro-Tirado, M. Charcos, M. L. Edwards, N. M. Lasso-Cabrera, A. Marin-Franch, S. N. Raines, K. Ackley, J. G. Bennett, A. J. Cenarro, B. Chinn, H. V. Donoso, R. Frommeyer, K. Hanna, M. D. Herlevich, J. Julian, P. Miller, S. Mullin, C. H. Murphey, C. Packham, F. Varosi, C. Vega, C. Warner, A. N. Ramaprakash, M. Burse, S. Punnadi, P. Chordia, A. Gerarts, H. de Paz Martín, M. Martín Calero, R. Scarpa, S. Fernandez Acosta, W. M. Hernández Sánchez, B. Siegel, F. Francisco Pérez, H. D. Viera Martín, J. A. Rodríguez Losada, A. Nuñez, Á. Tejero, C. E. Martín González, C. Cabrera Rodríguez, J. Molgó, J. Esteban Rodriguez, J. I. Fernández Cáceres, L. A. Rodríguez García, M. Huertas Lopez, R. Dominguez, T. Gaggstatter, A. Cabrera Lavers, S. Geier, P. Pessev, A. Sarajedini.
    Science; 2018 Apr; 360(6386):. PubMed ID: 29674566
    [No Abstract]   [Full Text] [Related]  

  • 6. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
    Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
    Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D; Yesner R
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum to: Kerr KM. The PD-L1 immunohistochemistry biomarker: two steps forward, one step back? J Thorac Oncol. 2018;13(3):291-294.
    J Thorac Oncol; 2018 Aug; 13(8):1230. PubMed ID: 30049371
    [No Abstract]   [Full Text] [Related]  

  • 9. mASH1 is Highly Specific for Neuroendocrine Carcinomas: An Immunohistochemical Evaluation on Normal and Various Neoplastic Tissues.
    Altree-Tacha D; Tyrrell J; Li F
    Arch Pathol Lab Med; 2017 Feb; 141(2):288-292. PubMed ID: 27628324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial." Gravis G, Fizazi K, Joly F, Oudard S, Priou F, Esterni B, Latorzeff I, Delva R, Krakowski I, Laguerre B, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M, Medical Oncology and Biostatistics, Institut Paoli-Calmettes, Marseille, France. Lancet Oncol 2013;14(2):149-58 [Epub 2013 Jan 8].
    Trump DL
    Urol Oncol; 2013 Nov; 31(8):1845. PubMed ID: 24210084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine tumors of the genital tract.
    Eichhorn JH; Young RH
    Am J Clin Pathol; 2001 Jun; 115 Suppl():S94-112. PubMed ID: 11993694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
    Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
    Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.
    Pelosi G; Masullo M; Leon ME; Veronesi G; Spaggiari L; Pasini F; Sonzogni A; Iannucci A; Bresaola E; Viale G
    Virchows Arch; 2004 Nov; 445(5):449-55. PubMed ID: 15375659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors.
    Derks JL; van Suylen RJ; Thunnissen E; den Bakker MA; Smit EF; Groen HJ; Speel EJ; Dingemans AM
    J Thorac Oncol; 2016 Apr; 11(4):593-602. PubMed ID: 26776865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for genes associated with natural killer cell mediated cytotoxicity in pneumonia mice infected with influenza virus and regulation of two herbal anti-virus formulas].
    Lu NN; Liu Q; Gu LG; Zhou XP; Wu J; Qiu ZJ; Zhang HC; Chao EX; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jun; 25(6):322-6. PubMed ID: 23739563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of neural-cadherin in pulmonary epithelial tumours.
    Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
    Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.